Paysign, Inc. (PAYS) Seasonal Returns Chart - Yahoo Finance
The article provides a seasonal returns chart for Paysign, Inc. (PAYS), displaying the average monthly price return from 2016 to 2026. It includes current stock data such as the price, daily change, and after-hours trading information. The page also features various financial market data and navigation options for Yahoo Finance users.
Paysign (NASDAQ:PAYS) Stock: Insider Joan Herman Sells 30,000 Shares
Paysign EVP Joan Herman sold 30,000 shares of company stock for $279,000 at an average price of $9.30 under a pre-arranged Rule 10b5-1 plan, retaining 579,421 shares. The company recently exceeded quarterly expectations with EPS of $0.11 and revenue of $30.8 million. Analysts have a "Moderate Buy" rating for PAYS with an average target price of $14.81.
Paysign evp Joan Herman sells $278,886 in common stock
Joan M. Herman, Executive Vice President of Operations and a director at Paysign, Inc. (NASDAQ:PAYS), sold 30,000 shares of the company’s common stock for $278,886 on November 16, 2026, through a pre-arranged trading plan. This transaction occurred after the stock delivered a 97% return over the past year, with InvestingPro analysis indicating Paysign may be undervalued. The company also recently reported stronger-than-expected Q3 2026 financial results, surpassing revenue and earnings forecasts and raising its full-year outlook.
Paysign evp Joan Herman sells $278,886 in common stock By Investing.com
Joan M. Herman, Executive Vice President of Operations and a director at Paysign, Inc. (NASDAQ:PAYS), sold 30,000 shares of the company’s common stock for $278,886 on November 16, 2026, pursuant to a pre-arranged trading plan. Despite the insider sale, Paysign's stock has seen a 97% return over the past year and its PEG ratio of 0.17 suggests it is undervalued. The company recently reported stronger-than-expected Q3 2026 financial results, with adjusted earnings and revenue surpassing Wall Street forecasts.
Paysign (PAYS) director sells 30,000 shares under trading plan, retains 579,421 directly.
Paysign, Inc. (PAYS) director Joan M. Herman sold 30,000 shares of common stock on November 16, 2026, at a weighted average price of $9.2962 per share, as part of a Rule 10b5-1 trading plan adopted in September 2025. Following this transaction, Herman directly holds 579,421 shares. The sale involved multiple transactions with prices ranging from $9.2101 to $9.3900.
Form 4 Paysign Inc: Joan M. Herman (Director, EVP, Operations) For: 16 November
This article reports on a Form 4 filing for Paysign Inc., detailing an insider transaction by Joan M. Herman, who serves as a Director and EVP of Operations. The filing pertains to activity on November 16th. The article emphasizes the release of this financial disclosure related to PAYS.
A fund and its manager report a passive stake spanning 4.11 million Paysign (PAYS) shares.
Topline Capital Management, LLC and Topline Capital Partners, LP, along with Collin McBirney, have reported a 7.2% passive stake in Paysign, Inc. (PAYS), totaling 4,111,461 common shares as of November 13, 2026. This amended ownership report, filed as a SCHEDULE 13G/A, indicates that the fund and its manager hold sole voting and dispositive power over these shares, with Collin McBirney reporting shared voting and dispositive power. The filing emphasizes that the acquisition is in the ordinary course of business and not for changing or influencing control of Paysign.
Paysign, Inc. (NASDAQ:PAYS) Stock Has Average Price Target of $14.81 According to Brokerages
Paysign, Inc. (NASDAQ:PAYS) has an average price target of $14.81 from brokerages, with a "Moderate Buy" rating. The company recently exceeded third-quarter earnings expectations, reporting an EPS of $0.11 on revenue of $30.8 million, surpassing analyst forecasts. Despite some mixed brokerage reactions, including Lake Street raising its target and Maxim Group downgrading the stock, analyst sentiment remains largely positive.
PaySign downgraded by Maxim Group
PaySign (NASDAQ: PAYS) has been downgraded by Maxim Group. This article provides historical context for PAYS's stock performance following previous headlines, noting a median move of 4.0% after 15 past sessions. It also explains what an analyst downgrade means and offers related research tools on Quantisnow.
Paysign Projects 2026 Revenue of $114 Million to $117 Million
Paysign, Inc. projects 2026 revenue to be between $114 million and $117 million. This projection comes as a customer transition involving 113 plasma centers is expected to reduce fourth-quarter revenue by $1.5 million and gross profit by $700,000. Despite this, the company expects patient affordability programs to drive future revenue growth and margin expansion, with third-quarter revenue, operating income, and adjusted EBITDA reaching record highs.
Q3 revenue rises 42.6% at Paysign (PAYS), but a customer plans to move plasma centers elsewhere.
Paysign (PAYS) reported a significant revenue increase of 42.6% to $30.8 million in Q3 2026, driven largely by its pharma patient affordability programs. However, the company anticipates a revenue and gross profit reduction starting in Q4 2026, as a customer intends to transition 113 plasma centers to a different provider by year-end. These centers contributed $2.8 million in revenue and $1.3 million in gross profit in Q3 2026.
Paysign 3Q 2026: Revenue $30.8M, EPS $0.11 — 10-Q Summary
Paysign (PAYS) reported a significant increase in revenue and net income for Q3 2026, driven by new pharma patient affordability programs and growth in plasma donations. Revenue rose 42.6% to $30.8M, and diluted EPS increased 175% to $0.11. The company's gross margin also improved, though it anticipates a revenue reduction in Q4 2026 due to a plasma customer transition.
PaySign Reports Q3 2026 Revenue Surge with Pharma Segment More Than Doubling Year-Over-Year
PaySign, Inc. (NASDAQ:PAYS) reported a significant revenue surge in Q3 2026, with total revenue reaching $30,800,158, up from $21,596,478 in Q3 2025. The pharmaceutical segment was a major driver, more than doubling its revenue to $16,620,579. Net income also saw a substantial increase, rising to $6,735,694 for the quarter.
PaySign Q3 2026 Earnings Call Transcript
PaySign Inc. reported record third-quarter 2026 results, with revenue growing 43% year-over-year to $30.8 million and net income increasing over 200% to $6.7 million. This growth was primarily driven by its patient affordability segment, which doubled its revenue and expanded gross margins to 64.7%. Despite the loss of a major plasma customer, PaySign remains optimistic about offsetting this with new business and expects full-year revenue between $114 million and $117 million.
Paysign, Inc. (PAYS) Tops Q3 EPS by 6c
Paysign, Inc. (PAYS) reported Q3 EPS of $0.11, significantly exceeding the analyst estimate of $0.05 by $0.06. The company's revenue for the quarter also surpassed expectations, coming in at $30.8 million against a consensus estimate of $28.61 million. This strong financial performance for the third quarter indicates Paysign's ability to outperform market predictions.
Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%
Paysign, Inc. announced record financial results for the third quarter of 2026, with revenues reaching $30.8 million, a 42.6% increase from the previous year, driven primarily by strong growth in patient affordability programs. The company also saw its operating margin more than triple to 23.8% and significantly raised its full-year 2026 guidance for profitability metrics. Despite the upcoming transition of a plasma customer's 113 centers to another provider, Paysign remains confident in its growth trajectory due to the continued momentum in patient affordability and future software platform opportunities.
Earnings call transcript: Paysign tops Q3 2026 estimates as stock rebounds
Paysign (PAYS) reported Q3 2026 results that significantly surpassed Wall Street estimates, with adjusted EPS of $0.11 and revenue of $30.8 million. The company's patient affordability business was a key growth driver, with revenue more than doubling year-over-year. Despite the loss of 113 plasma centers from a major customer, Paysign raised its full-year profit and margin outlook, reflecting strong operating leverage and the robust performance of its higher-margin patient affordability segment.
Paysign, Inc. (PAYS) Seasonal returns chart
This article from Yahoo Finance presents a seasonal returns chart for Paysign, Inc. (PAYS). It displays the average monthly price return for the company's stock from 2016 to 2026, offering insights into its historical seasonality. The page also provides current stock information, including real-time prices and after-hours trading data.
Paysign, Inc. Estimates – NASDAQ:PAYS
This article provides an overview of Paysign, Inc. (NASDAQ: PAYS) financial estimates and actuals through the TradingView platform. It highlights access to reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics, allowing users to compare results with average, high, and low estimates and visualize trends over time. The content emphasizes that the information is not investment advice and encourages users to conduct their own research.
PaySign Inc (PAYS) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 62/100
PaySign Inc (PAYS) shares increased by 3.6% to $15.34, marking a 197.9% year-to-date gain, yet GuruFocus's GF Value suggests the stock is 123.9% overvalued at $6.85. The company holds an "Above Average" GF Score of 62/100, driven by strong profitability but hindered by poor valuation and moderate growth. Insider selling of $8.3 million with no purchases further indicates a lack of confidence from institutional investors, advising caution for potential investors.
Form 4 Paysign Inc: Mark Newcomer (Director, 10% Owner, CEO) For: 9 October
This article reports on a Form 4 filing for Paysign Inc., indicating a transaction by Mark Newcomer, who serves as a Director, 10% Owner, and CEO of the company. The filing pertains to activity on October 9th. The content is brief and provides no further details beyond this announcement.
Paysign, Inc. (PAYS) Stock Price, News, Quote & History
This article provides comprehensive financial information for Paysign, Inc. (PAYS), including its current stock price, recent performance metrics, key financial ratios, and analyst ratings. It details the company's business overview, offering prepaid card programs and payment processing services, and highlights its strong year-to-date and multi-year returns.
Form 4 Paysign Inc: Mark Newcomer (Director, 10% Owner, CEO) For: 9 October
This article reports on a Form 4 filing for Paysign Inc., detailing activity by Mark Newcomer, who holds roles as Director, 10% Owner, and CEO. The filing pertains to actions taken on October 9. The report is succinct, focusing solely on this insider transaction.
Form 4 Paysign Inc: Mark Newcomer (Director, 10% Owner, CEO) For: 9 October By Investing.com
This article reports on a Form 4 filing for Paysign Inc., detailing an insider transaction by Mark Newcomer, who holds roles as Director, 10% Owner, and CEO. The filing pertains to activity on October 9th, 2026. The article specifically highlights the company's stock symbol PAYS, which showed a 2.70% increase.
Insider Selling: Paysign (NASDAQ:PAYS) CEO Sells 50,000 Shares of Company Stock
Paysign CEO Mark Newcomer sold 50,000 shares of PAYS stock for $767,000 on October 9th, as part of a pre-arranged trading plan, reducing his direct ownership by 0.55%. The company's stock has performed strongly, trading near its 52-week high, and recently beat earnings and revenue expectations. Analysts maintain a "Buy" rating with an average price target of $15.00.
Paysign CEO Mark Newcomer sells $766,895 of PAYS stock
Paysign CEO Mark Newcomer sold 50,000 shares of PAYS stock for $766,895 on October 9, 2026, pursuant to a pre-arranged trading plan. This transaction occurred as the stock trades near its 52-week high and is considered overvalued by InvestingPro. Despite the sale, Newcomer still directly holds over 9 million shares, and the company recently reported strong Q2 2026 earnings, surpassing Wall Street estimates, and received a raised price target from DA Davidson.
Form 4 Paysign Inc: Mark Newcomer (Director, 10% Owner, CEO) For: 9 October
This article reports on a Form 4 filing for Paysign Inc., indicating a transaction by Mark Newcomer, who holds roles as Director, 10% Owner, and CEO. The filing specifically pertains to activity on October 9th. No further details about the nature of the transaction are provided in the snippet.
After selling 50,000 shares under a trading plan, Paysign (PAYS) CEO holds 9,113,002 shares directly.
Paysign, Inc. CEO Mark Newcomer sold 50,000 shares of common stock on October 9, 2026, for a weighted average price of $15.3379 per share under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Newcomer directly holds 9,113,002 shares of Paysign common stock. The sale, which generated approximately $767,000, was executed in multiple transactions ranging from $15.3301 to $15.3410 per share.
Form 4 Paysign Inc: Mark Newcomer (Director, 10% Owner, CEO) For: 9 October
This article reports on a Form 4 filing for Paysign Inc., detailing an insider transaction by Mark Newcomer, who serves as a Director, 10% Owner, and CEO of the company. The transaction date specified in the filing is October 9. This information is relevant for investors tracking insider activity at PAYS.
Paysign Q3FY26 Results: Earnings call scheduled for November 9, 2026
Paysign Inc. has scheduled its Q3 FY26 earnings call for Monday, November 9, 2026, at 5:00 pm Eastern time. The company will discuss its financial results, with specific dial-in and webcast details provided for interested parties. Analysts wishing to ask questions must register by November 6, 2026, and a replay will be available until January 25, 2027.
Paysign to Host Third Quarter 2026 Earnings Call
Paysign, Inc. (NASDAQ: PAYS) announced it will host its third quarter 2026 earnings call on Monday, November 9, 2026, at 5:00 p.m. Eastern time. The company, which provides patient affordability programs and payment solutions for the life sciences industries, detailed dial-in and webcast information for participants. A replay will be available until January 25, 2027, and financial professionals wishing to ask questions must register by November 6, 2026.
Paysign to Host Third Quarter 2026 Earnings Call
Paysign, Inc. (NASDAQ: PAYS) announced it will host its third quarter 2026 earnings call on Monday, November 9, 2026, at 5:00 p.m. Eastern time. The call will discuss the company's financial results and provide an opportunity for financial professionals to ask questions. Paysign is a leading provider of patient affordability programs and donor compensation solutions for the life sciences industries.
Paysign (NASDAQ:PAYS) Stock Price Up 3.8% - Should You Buy?
Paysign (NASDAQ:PAYS) saw its stock price increase by 3.8% to $14.90, bringing its market capitalization to approximately $836 million, despite trading volume being well below average. Analysts maintain a "Buy" rating with an average price target of $15.00, and the company recently exceeded quarterly earnings expectations with an EPS of $0.11 against a $0.06 consensus. While insiders have sold shares worth about $5.3 million, they still own 24.5% of the company, and institutional ownership stands at 25.89% with recent increases in positions.
Weekly Recap: Pharma affordability revenue +89% and DA Davidson $15 target
Paysign, Inc. (NASDAQ:PAYS) is experiencing significant growth, with its Pharmaceutical Patient Affordability revenue increasing by 89% year-over-year in Q2. An analyst projects active campaigns to surge to 186 by 2026, while DA Davidson reiterated a Buy rating with a $15 price target, suggesting a 16.7% upside.
Paysign Inc. Research & Ratings | 2ZE
This article provides research and ratings for Paysign Inc. (2ZE) listed on the Frankfurt market. It includes key financial data such as market value, shares outstanding, EPS, and P/E ratio, but notes that analyst ratings, average price targets, and stock price targets are not available. The report also details various data sources and disclaimers regarding the information provided.
Paysign Inc. Financials | 2ZE
This article provides a financial overview of Paysign Inc. (2ZE) on the Frankfurt market. It includes key financial metrics such as market value, shares outstanding, EPS, P/E ratio, and recent trading activity. The data is presented with disclaimers regarding its informational purpose and sources.
Paysign Insiders Made A Wise Decision By Selling US$743k Worth Of Stock
The article discusses how Paysign (NASDAQ:PAYS) insiders sold US$743k worth of stock over the last year at an average price of US$6.27. This selling activity, coupled with the stock's current trading price of US$3.88, suggests that the insiders made a timely decision, avoiding significant losses. The analysis also covers Paysign's earnings growth and valuation, noting the stock may be undervalued compared to its intrinsic value despite insider selling.
Paysign (NASDAQ:PAYS) Sets New 1-Year High - Here's What Happened
Paysign (NASDAQ:PAYS) recently hit a new 52-week high, trading at $14.93, driven by strong quarterly results where it exceeded EPS and revenue expectations. Analysts maintain a "Buy" rating with a consensus price target of $15.00, though insider selling of approximately $5.3 million occurred alongside increased institutional ownership.
Paysign (NASDAQ:PAYS) Stock Jumps 7.1% - Here's Why
Paysign (NASDAQ:PAYS) stock jumped 7.1% after receiving bullish analyst ratings and reporting strong quarterly results that beat expectations. Lake Street Capital and DA Davidson both raised their price targets to $15, aligning with the consensus "Buy" rating. The company also provided optimistic fiscal 2026 EPS guidance, despite recent insider share sales.
PAYS Maintained by DA Davidson -- Price Target Raised to $15.00
DA Davidson has maintained a 'Buy' rating for PaySign (PAYS) and raised its price target from $12.00 to $15.00, reflecting optimism about the company's growth potential. However, GuruFocus indicates that PAYS is 94.6% overvalued with a current price of $13.15 against a GF Value™ of $6.76, and insider activity shows significant selling. Despite strengths in profitability and financial stability, investors are advised to approach PAYS with caution due to its high valuation and cautious sentiment from institutional investors and insiders.
DA Davidson raises Paysign stock price target to $15 on growth outlook By Investing.com
DA Davidson has increased its price target for Paysign Inc. (NASDAQ: PAYS) to $15.00 from $12.00, reiterating a Buy rating. This adjustment follows a detailed analysis of the Patient Affordability niche and positive meetings with management, leading to increased confidence in the company's strong growth prospects. Paysign recently reported Q2 2026 earnings that surpassed Wall Street expectations, prompting the firm to raise its 2027 and introduce 2028 forecasts.
DA Davidson raises Paysign stock price target to $15 on growth outlook
DA Davidson has increased its price target for Paysign Inc. (NASDAQ:PAYS) to $15 from $12, maintaining a Buy rating, based on stronger growth prospects in the Patient Affordability niche. The firm also revised its 2027 forecasts and introduced 2028 forecasts. This follows Paysign's strong Q2 2026 earnings, which surpassed Wall Street expectations for both revenue and EPS, leading the company to raise its full-year outlook.
2ZE | Paysign Inc. Stock Overview (Germany: Frankfurt)
This article provides an overview of Paysign Inc. (2ZE) stock performance on the Frankfurt exchange, including key financial metrics like market value, EPS, and P/E ratio. It also lists the current stock price, day range, 52-week range, and trading volume. The data is presented with disclaimers about its informational purpose and sources.
Paysign Inc. Advanced Charts | 2ZE
This page provides advanced chart information for Paysign Inc. (2ZE) on the Frankfurt market. It displays real-time market data such as current price, daily range, 52-week range, volume, market value, EPS, and P/E ratio. The page also details the various data sources for the financial information provided.
Paysign (NASDAQ:PAYS): High-Growth Leadership With Strong Momentum
Paysign Inc. (NASDAQ: PAYS) exhibits strong growth potential based on a CAN SLIM analysis, showing exceptional quarterly and annual earnings and revenue growth, along with a robust return on equity and zero debt. While its technical performance is strong, valuation and supply-side concerns like share dilution present potential risks. The article recommends PAYS for a watchlist, suggesting a wait for a clearer entry point due to recent price volatility.
Paysign (NASDAQ:PAYS) EVP Joan Herman Sells 38,900 Shares
Paysign's EVP Joan Herman sold 38,900 shares of the company's stock for over $450,000 under a Rule 10b5-1 trading plan, retaining a significant stake worth approximately $7.15 million. The transaction follows a period where Paysign's stock performance has been strong, with shares rising 5.1% to $12.42, and the company exceeding quarterly EPS and revenue estimates. Analysts maintain a "Buy" rating for Paysign with a consensus target price of $14.00, reflecting confidence in its future performance.
Paysign (PAYS) ops chief sells nearly 60K shares under preset plan
Paysign, Inc. (PAYS) director and EVP of Operations, Joan M. Herman, sold a total of 59,904 shares of common stock in open-market transactions under a Rule 10b5-1 trading plan. The sales occurred on September 15 and 16, 2026, at weighted average prices of $12.3819 and $11.7437, respectively. These transactions were made according to a plan adopted on September 12, 2025.
Paysign EVP, operations Joan Herman sells $716,899 in shares
Joan Herman, EVP of Operations and a Director at Paysign Inc. (NASDAQ:PAYS), sold $716,899 worth of company stock in mid-September through two transactions, executed under a Rule 10b5-1 trading plan. These sales occurred as the stock trades near its 52-week high after a significant surge. Despite the insider sales and an InvestingPro analysis suggesting the stock is slightly overvalued, Paysign recently exceeded Q2 2026 earnings expectations and raised its full-year outlook.
Paysign EVP, operations Joan Herman sells $716,899 in shares By Investing.com
Joan M. Herman, EVP of Operations and a Director at Paysign, Inc. (NASDAQ:PAYS), sold common stock worth $716,899 in two transactions in mid-September. The sales were executed under a Rule 10b5-1 trading plan at weighted average prices between $11.7437 and $12.3819 per share, following a significant 286% surge in the stock over the past six months. Despite the sales, Ms. Herman still directly holds 609,421 shares of Paysign common stock, and the company recently surpassed Q2 2026 earnings expectations, raising its full-year outlook.
Paysign (PAYS) insider sells 150K shares, keeps 461K
Paysign's Chief Innovation Officer, Michael C. Ngo, indirectly sold a total of 150,000 shares of common stock through Gamma Innovation LLC on September 8-9, 2026, at weighted average prices of $12.8494 and $12.74 per share. These sales were open-market transactions and were not made under a Rule 10b5-1 trading plan. Despite the sales, Ngo retains a direct holding of 461,336 Paysign shares.